As regenerative medicine expands, so does the noise.
Dozens of companies claim to offer clinical-grade stem cell therapies. But few meet the regulatory, scientific, and ethical standards required for safe, effective use. In Florida, physicians are now legally permitted to offer certain non-FDA-approved biologics for orthopedics, wound care, and pain management. The opportunity is real. So is the risk.
Here’s how to separate legitimate providers from the rest.
1. 3D Culturing vs 2D Culturing: Why It Matters
Laboratories expand mesenchymal stem cells (MSCs) using traditional 2D monolayer culture, where cells grow attached to flat plastic surfaces such as culture flasks. This approach has historically been common because it is simple and scalable for research and manufacturing.
Source:
https://www.sciencedirect.com/science/article/pii/S245231862300017X
However, 2D systems do not fully replicate the three dimensional microenvironment found in living tissues, which can influence how cells interact with each other and with their surrounding matrix.
Source:
https://www.mdpi.com/2306-5354/11/12/1199
3D culture systems allow cells to form spheroids or aggregates that more closely resemble native tissue architecture and increase cell to cell interaction.
Source:
https://academic.oup.com/stcltm/article/14/3/szae093/7935377
Some studies report that MSCs grown in 3D environments produce higher levels of extracellular vesicles such as exosomes compared with conventional 2D cultures.
Source:
https://link.springer.com/article/10.1007/s13770-023-00551-y
In one study using umbilical cord derived MSCs, a scalable 3D culture system produced about 20 times more exosomes than a 2D culture under the tested conditions.
Source:
https://www.sciencedirect.com/science/article/pii/S1525001618304568
Because culture conditions influence cell behavior and secreted factors, understanding how cells are expanded and cultured can be relevant when evaluating biologic manufacturing processes.
2. Post-Thaw Viability: 95 Percent or Higher Is Non-Negotiable
Cryopreservation can damage stem cells. A high post-thaw viability means that after warming, the majority of cells remain alive and functional.
The industry standard for clinical-grade MSCs is a post-thaw viability between 95 and 98 percent. This ensures that what you inject contains active, effective cells rather than dead material that may trigger inflammation.
Every provider should supply batch-specific post-thaw reports. If they can’t, or offer a single document reused across lots, that’s a red flag. Always verify viability before you administer.
3. Xeno-Free: Clean Inputs Matter
Xeno-free means that no animal derived components are used during the cell culture process. In regenerative medicine manufacturing, this typically means avoiding materials such as fetal bovine serum (FBS), which has historically been used to provide nutrients and growth factors for cell expansion.
Fetal bovine serum is a complex mixture derived from the blood of fetal calves and has been widely used in cell culture because it supports cell growth and proliferation.
https://www.mdpi.com/1422-0067/25/19/10627
However, the use of animal derived serum introduces several scientific concerns. FBS contains undefined biological components, which can lead to batch to batch variability and inconsistent experimental outcomes.
https://www.sciencedirect.com/science/article/pii/S1465324922007046
4. cGMP and AATB Laboratory Standards: Know What You’re Injecting
Serious biologics manufacturers operate under strict laboratory standards.
Look for products produced in facilities that follow cGMP (Current Good Manufacturing Practices) and are accredited by the American Association of Tissue Banks (AATB).
These labs operate under pharmaceutical-grade conditions with controlled environments, validated manufacturing processes, and documented quality systems. Many are also FDA registered and inspected, adding another layer of oversight and accountability.
This level of compliance helps ensure the biologic’s source, processing, sterility, potency, and viability are carefully documented and tested before it ever reaches a clinic.
If a provider cannot show proof of cGMP manufacturing, AATB accreditation, or FDA inspection, there is no reliable way to verify how the biologic was sourced, processed, or handled.
That uncertainty creates risk for both your patients and your practice.
5. Third Party Testing: One Test Is Never Enough
Every vial should undergo these levels of validation:
-
Third-party testing for potency and purity
-
Post-thaw viability reports matched to the lot shipped
Without testing, you cannot guarantee that what’s on the label is what’s in the vial. And in biologics, inconsistency means clinical failure.
Demand full transparency. If your supplier doesn’t provide it, move on.
What to Avoid
-
No clear origin or manufacturer listed
-
Missing or reused certificates of analysis
-
Use of fetal bovine serum
-
No post-thaw viability data
-
Silence around legal compliance
Why BioRegen Is the Gold Standard
BioRegen delivers biologics designed for clinical use, built on science, and aligned with Florida law.
-
All stem cells are 3D-cultured and xeno-free
-
Each batch shows over 90 percent post-thaw viability, verified independently
-
All products are produced in a cGMP, cGTP, AATB and FDA-inspected lab
-
Every lot undergoes triple testing
-
All vials carry compliant labeling and full documentation
-
We provide you with informed consent templates, advertising notices, and legal guidance
You aren’t just buying a product. You’re gaining a clinical partner who protects your license, your patients, and your outcomes.
Get Started with Confidence
If you're a licensed MD or DO in Florida offering orthopedic, wound care, or pain management services, you now have access to biologics that meet both scientific and legal standards.
Book your onboarding consult or submit your license now at www.bioregenwellness.com
Let’s raise the standard of care, one vial at a time.
